bioAffinity Technologies (BIAF) closes $4M private placement deal

bioAffinity Technologies, Inc. (BIAF) has completed a $4 million private placement of its common stock. The placement included the sale of approximately 4.2 million shares at a price of $0.95 per share. This move is intended to provide the company with additional capital for its ongoing operations and development plans. For investors, this funding round is essential as it demonstrates the company's ability to raise capital, which could impact its growth potential.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.